These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31758264)

  • 21. The Society for Neuroscience 2009 meeting report, part 2.
    Dance A; Landhuis E; Strobel G
    J Alzheimers Dis; 2010; 19(4):1409-15. PubMed ID: 20308793
    [No Abstract]   [Full Text] [Related]  

  • 22. Amyloid-beta metal interaction and metal chelation.
    Cuajungco MP; Frederickson CJ; Bush AI
    Subcell Biochem; 2005; 38():235-54. PubMed ID: 15709482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative hypotheses related to Alzheimer's disease.
    Cubinkova V; Valachova B; Uhrinova I; Brezovakova V; Smolek T; Jadhav S; Zilka N
    Bratisl Lek Listy; 2018; 119(4):210-216. PubMed ID: 29663818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
    Savelieff MG; Lee S; Liu Y; Lim MH
    ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The English (H6R) familial Alzheimer's disease mutation facilitates zinc-induced dimerization of the amyloid-β metal-binding domain.
    Kozin SA; Kulikova AA; Istrate AN; Tsvetkov PO; Zhokhov SS; Mezentsev YV; Kechko OI; Ivanov AS; Polshakov VI; Makarov AA
    Metallomics; 2015 Mar; 7(3):422-5. PubMed ID: 25703165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A spectroscopic study of some of the peptidyl radicals formed following hydroxyl radical attack on beta-amyloid and alpha-synuclein.
    Tabner BJ; Turnbull S; King JE; Benson FE; El-Agnaf OM; Allsop D
    Free Radic Res; 2006 Jul; 40(7):731-9. PubMed ID: 16984000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycation in Parkinson's disease and Alzheimer's disease.
    Vicente Miranda H; El-Agnaf OM; Outeiro TF
    Mov Disord; 2016 Jun; 31(6):782-90. PubMed ID: 26946341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Residues in the synuclein consensus motif of the alpha-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid beta A4 peptide.
    Jensen PH; Sørensen ES; Petersen TE; Gliemann J; Rasmussen LK
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):91-4. PubMed ID: 7646476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing the mettle of PBT2 for Alzheimer's disease.
    Relkin NR
    Lancet Neurol; 2008 Sep; 7(9):762-3. PubMed ID: 18672401
    [No Abstract]   [Full Text] [Related]  

  • 30. Zinc-induced dimerization of the amyloid-β metal-binding domain 1-16 is mediated by residues 11-14.
    Kozin SA; Mezentsev YV; Kulikova AA; Indeykina MI; Golovin AV; Ivanov AS; Tsvetkov PO; Makarov AA
    Mol Biosyst; 2011 Apr; 7(4):1053-5. PubMed ID: 21350790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid-beta: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease.
    Kontush A
    Free Radic Biol Med; 2001 Nov; 31(9):1120-31. PubMed ID: 11677045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases.
    Atsmon-Raz Y; Miller Y
    ACS Chem Neurosci; 2016 Jan; 7(1):46-55. PubMed ID: 26479553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Benzothiazole Derivatives as Fluorescent Probes for Detection of β-Amyloid and α-Synuclein Aggregates.
    Watanabe H; Ono M; Ariyoshi T; Katayanagi R; Saji H
    ACS Chem Neurosci; 2017 Aug; 8(8):1656-1662. PubMed ID: 28467708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metallothioneins and synthetic metal chelators as potential therapeutic agents for removal of aberrant metal ions from metal-Aβ species.
    Xia N; Liu L
    Mini Rev Med Chem; 2014; 14(3):271-81. PubMed ID: 24456271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.
    Masliah E; Rockenstein E; Veinbergs I; Sagara Y; Mallory M; Hashimoto M; Mucke L
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12245-50. PubMed ID: 11572944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A meta-analysis and review examining a possible role for oxidative stress and singlet oxygen in diverse diseases.
    Petrou AL; Terzidaki A
    Biochem J; 2017 Aug; 474(16):2713-2731. PubMed ID: 28768713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson's and Alzheimer's diseases.
    Hannula MJ; Myöhänen TT; Tenorio-Laranga J; Männistö PT; Garcia-Horsman JA
    Neuroscience; 2013 Jul; 242():140-50. PubMed ID: 23562579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New biomarkers and drug targets for diagnosis and therapy of Alzheimer's disease (molecular determinants of zinc-dependent oligomerization of Β-amyloid)].
    Kozin SA; Makarov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):5-9. PubMed ID: 25909782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's disease-related lesions.
    Alafuzoff I
    J Alzheimers Dis; 2013; 33 Suppl 1():S173-9. PubMed ID: 22695621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differently selected D-enantiomeric peptides act on different Abeta species.
    Bartnik D; Funke SA; Andrei-Selmer LC; Bacher M; Dodel R; Willbold D
    Rejuvenation Res; 2010; 13(2-3):202-5. PubMed ID: 19954333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.